Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is China Medical System Holdings Net Margin %?
China Medical System HoldingsCHSYF +0.11%87 Net Margin % is 13.01% as of Dec. 2025, which is 59% below its 10-year median of 31.80. GuruFocus rates CHSYF with a GF Score™ of 87/100 and a GF Value™ of $1.30 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 961 Drug Manufacturers companies, China Medical System Holdings ranks better than 84.81% on this metric.
The historical rank and industry rank for China Medical System Holdings's Net Margin % or its related term are showing as below:
CHSYF'
s Net Margin % Range Over the Past 10 Years
Min: 18.1 Med: 31.8 Max: 36.43
Current: 18.1
CHSYF's Net Margin % is ranked better than 84.81% of 961
companies
in the Drug Manufacturers industry
Industry Median: 5.47
vs CHSYF: 18.10
China Medical System Holdings (OTCPK:CHSYF) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
China Medical System Holdings Net Margin % Related Terms
China Medical System Holdings Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, China Medical System Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Medical System Holdings Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Medical System Holdings's Net Margin % distribution charts can be found below:
* The bar in red indicates where China Medical System Holdings's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Medical System Holdings (CHSYF) has a Net Margin % of 13.01% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on China Medical System Holdings and its competitors. This is 59% below median its historical median of 31.80. Over the past decade, China Medical System Holdings' Net Margin % has ranged from 18.10 to 36.43. According to the industry distribution chart, China Medical System Holdings ranks #146 out of 961 companies in the Drug Manufacturers industry, placing it in the top 15.2%.
Is China Medical System Holdings' Net Margin % too high?
China Medical System Holdings' current Net Margin % of 13.01% is 59% below median its 10-year median of 31.80. Over the past 10 years, this metric has ranged from a low of 18.10 to a high of 36.43. The Drug Manufacturers industry median Net Margin % is 5.47. China Medical System Holdings' value of 13.01% is 137.8% above this industry median. Based on the distribution chart, China Medical System Holdings ranks #146 out of 961 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, China Medical System Holdings has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does China Medical System Holdings' Net Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, China Medical System Holdings ranks #146 out of 961 companies for Net Margin %. This places China Medical System Holdings in the top 15% of its industry — outperforming the majority of peers. The industry median Net Margin % is 5.47. China Medical System Holdings' value of 13.01% is 137.8% above this benchmark. Historically, China Medical System Holdings' own Net Margin % has ranged from 18.10 to 36.43 over the past decade. While the company's 10-year median is 31.80 vs. the industry median of 5.47, China Medical System Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.47, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Medical System Holdings's current Net Margin % of 13.01% is 137.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on China Medical System Holdings and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Medical System Holdings's current Net Margin % is 13.01%, which is 59% below median its own 10-year median of 31.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Medical System Holdings stock overvalued right now?
Based on GuruFocus' analysis, China Medical System Holdings (CHSYF) is currently considered Modestly Overvalued. The stock's GF Value™ is $1.30, compared to a current price of $1.57 — trading 20.8% above its estimated fair value. The current Net Margin % is 13.01%, which is 59% below median its 10-year median of 31.80 and 137.8% above the Drug Manufacturers industry median of 5.47. China Medical System Holdings' overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For China Medical System Holdings (CHSYF), the current Net Margin % is 13.01% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Medical System Holdings (CHSYF) Overvalued in 2026?
Based on GuruFocus' analysis, China Medical System Holdings stock appears to be overvalued.
The current stock price of $1.57 is trading 20.8% above its estimated GF Value™ of $1.30.
GuruFocus considers China Medical System Holdings to be Modestly Overvalued.
Key valuation signals for CHSYF:
Net Margin %: 13.01% (59% below median its 10-year median of 31.80)
GF Value™: $1.30 vs. price of $1.57 (20.8% above fair value)
Industry Position: 137.8% above the Drug Manufacturers median (#146 of 961)
No single metric tells the full story. See the CHSYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Medical System Holdings Business Description
China Medical System Holdings Ltd is a holding company. Along with its subsidiaries, it is engaged in the research and development, production, promotion and sale of medicines. The company's reportable segments are: (i) Integrated pharmaceuticals portfolio and (ii) Skin diseases related business. The majority of the company's revenue, which consists of pharmaceutical products sales, is derived from the integrated pharmaceuticals portfolio segment.
87GF Score
Get the complete analysis for CHSYF
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHSYF has been successfully added to your 
